Research location
Suining
Sichuan, China
Advertisement
Research activity in Suining
Sichuan, ChinaCureCurrent currently publishes aggregate city-level research activity for this location: 25 trials and 25 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Suining
25 linked trials · page 1 of 1Multicenter, Single-Arm, Prospective Phase II Study of Neoadjuvant Cryo-Thermal Ablation Combined With Toripalimab and Chemotherapy for Resectable Stage IB-IIIB Non-Small Cell Lung CancerNCT07855965 · 2026-09-10 · 1 site observation
RECRUITING
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast CancerNCT06993506 · 2026-05-28 · 1 site observation
RECRUITING
Phase II Study of RC1416 Injection in COPDNCT07402551 · 2026-03-06 · 1 site observation
RECRUITING
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 InflammationNCT07177339 · 2025-10-20 · 1 site observation
RECRUITING
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.NCT07028853 · 2025-09-28 · 1 site observation
RECRUITING
TQB2930 Injection for the Treatment of HER2-positive Advanced Breast CancerNCT07047365 · 2025-07-25 · 1 site observation
RECRUITING
TQC2731 Clinical Trial for the Treatment of Severe Asthma With InjectionNCT06829784 · 2025-03-21 · 1 site observation
RECRUITING
A Trial Comparing GQ1005 and T-DM1 in Patients With HER2-Positive Unresectable or Metastatic Breast CancerNCT07673029 · 2025-01-10 · 1 site observation
RECRUITING
Adjuvant Immune Checkpoint Inhibitor Versus Observation After Neoadjuvant Immunochemotherapy and Surgery in High-Risk NSCLCNCT07748325 · 2025-01-10 · 1 site observation
RECRUITING
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)NCT06136624 · 2023-12-31 · 1 site observation
RECRUITING
A Phase II Clinical Trial on the Efficacy and Safety of TQC3721 Inhalation PowderNCT07252908 · 2025-12-22 · 1 site observation
COMPLETED
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese SubjectsNCT06738979 · 2025-03-20 · 1 site observation
COMPLETED
A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06789289 · 2025-03-17 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06707883 · 2024-12-31 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary DiseaseNCT06527144 · 2024-09-14 · 1 site observation
COMPLETED
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic TNBCNCT06419621 · 2024-06-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast CancerNCT06115902 · 2023-11-17 · 1 site observation
COMPLETED
A Clinical Trial of TQC3721 Suspension for Inhalation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease.NCT05987371 · 2023-08-23 · 1 site observation
COMPLETED
Lobectomy-First vs. Lymphadenectomy-First for Operable NSCLC (LOFTY)NCT06577792 · 2023-08-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast CancerNCT05780567 · 2023-03-30 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of SPH3127 Tablets on Treating the Diabetic Kidney DiseaseNCT05593575 · 2023-03-22 · 1 site observation
COMPLETED
To Evaluate the Efficacy and Safety of TQB3616 in Combination With Fulvestrant Versus Placebo in Combination With Fulvestrant in Previously Untreated Hormone-receptor (HR)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Advanced Breast CancerNCT05365178 · 2022-07-01 · 1 site observation
ACTIVE_NOT_RECRUITING
To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan IsoproxilNCT06500689 · 2021-12-30 · 1 site observation
COMPLETED
Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)NCT04246177 · 2020-05-22 · 1 site observation
TERMINATED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.